Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2025-12-24 @ 2:53 PM
NCT ID:
NCT00356759
Eligibility Criteria:
Inclusion Criteria:
* Patients on long-term warfarin (for prophylaxis of arterial embolism in patients with atrial fibrillation or mechanical heart valve replacement, or secondary prophylaxis after VTE) with a target INR of 2.0-3.0 or 2.5-3.5,
* Anticoagulant therapy managed by the clinic (HHS - General Hospital) for at least 6 months prior to enrolment, and
* Maintenance dose of warfarin unchanged for the previous 6 months or longer.
Exclusion Criteria:
* Age \<18 years,
* Life expectancy of less than 1 year,
* Attending physician believes the patient is not suitable for the study (e.g. psychiatric disorder, history of non-compliance),
* Geographic inaccessibility or
* Failure to obtain written consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00356759
Study Brief:
Protocol Section:
NCT00356759